DeFeng Information's Low-Code PaaS Wins Dual Awards at Future Healthcare 100 Summit 2023
Recently, the 7th Future Healthcare 100 Conference, themed “Beyond East and West,” was successfully held in Shanghai, where the “2023 Future Healthcare 100 Series Rankings” were officially released.
Shanghai Defan Information Technology Co., Ltd. (hereinafter referred to as “Defan Info”) has successfully won two prestigious awards: the “Top 100 China Innovative Business and Supply Chain Services List” and the “Low-Code – Healthcare, Value Domain List,” thanks to its strong technical capabilities, excellent practical expertise, and significant growth prospects in the pharmaceutical and healthcare sector, drawing widespread attention from the industry.
Launched in 2015, the Future Healthcare 100 list is China’s first ranking dedicated to innovative medical companies that are not publicly listed. It was introduced by VB100, VCBeat, and Eggshell Research Institute. The list aims to identify Chinese innovators who truly represent the future of healthcare, uncover the core driving forces behind China’s future healthcare industry, and promote innovation and transformation within the health and medical sector.
The Value Sector Awards are determined through multi-dimensional, comprehensive insights and explorations, including investor interviews, journalist interviews, and industry report analysis. Based primarily on capital attention, and supplemented by considerations of media focus, annual performance data热度 of healthcare enterprises, and the future prosperity outlook of the healthcare industry, the awards evaluate over 60 sub-sectors across four major tracks: medical devices, biopharmaceuticals, digital health, and healthcare services. The process identifies the most representative value sectors of the year and selects the most representative and high-growth innovative enterprises within each value sector.
This demonstrates that Defan Information stood out from thousands of enterprises by continuously empowering the digital transformation of healthcare processes and equipment, as well as hospital information system construction, through its Defan Cloud low-code PaaS platform. It has also demonstrated excellence in multiple dimensions, including innovation and breakthroughs in the low-code sector, value growth, and industry contributions.
Defan has been deeply engaged in the manufacturing sector for nearly a decade, making significant contributions to the pharmaceutical and healthcare industry. Leading enterprises such as Yunnan Baiyao, China Resources Double-Crane, China Resources Sanjiu, China Resources Jiuxin, Sinopharm Group, Novartis Pharmaceuticals, Chongqing Pharmaceutical, Hutchison Whampoa Pharmaceuticals, and Lei Yun Shang have all partnered with Defan’s low-code PaaS platform.
In the future, Defan will empower the industry by leveraging its benchmark best practices, continuously supporting the digital transformation of enterprises in the pharmaceutical and healthcare sectors, and contributing to the innovation and transformation of the health and medical industry through its low-code PaaS platform.